Bioregenx (BRGX) Cash from Financing Activities (2022 - 2026)
Bioregenx (BRGX) posted quarterly Cash from Financing Activities of -$50206.0 for Q1 2026, down 382.05% year-over-year from $17800.1 in Q1 2025, and down 13.73% quarter-over-quarter from -$44143.0 in Q4 2025.
Bioregenx (BRGX) Cash from Financing Activities (2022 - 2026) Analysis & Trends
Bioregenx's Cash from Financing Activities history runs 5 years deep, the most recent figure standing at -$50206.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 382.05% year-over-year to -$50206.0; the TTM figure through Mar 2026 stood at -$6693.0 (down 104.49% YoY), while the FY2025 annual figure was $33098.0, down 92.51% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$50206.0, down from -$44143.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $513370.0 in Q4 2023, with the low at -$50206.0 in Q1 2026.
- The 5-year median for Cash from Financing Activities is $39118.5 (2022), against an average of $104393.9.
- The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities surged 14571.91% in 2023, then tumbled 535.7% in 2025.
- Bioregenx's Cash from Financing Activities stood at $3499.0 in 2022, then soared by 14571.91% to $513370.0 in 2023, then sank by 101.35% to -$6944.0 in 2024, then sank by 535.7% to -$44143.0 in 2025, then declined by 13.73% to -$50206.0 in 2026.
- Business Quant data shows BRGX's Cash from Financing Activities at -$50206.0 in Q1 2026, -$44143.0 in Q4 2025, and $70833.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | -262.53 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | -354.13 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | -137.18 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | 3.02 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | -30.48 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 512.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | -7.10 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | -100.55 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Bioregenx | 9.72 Mn | 9.67 Mn | 348,288.00 | -50,206.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50,206.00 |
| Mar 31, 2026 | -50,206.00 |
| Dec 31, 2025 | -44,143.00 |
| Dec 31, 2025 | -44,143.00 |
| Sep 30, 2025 | 70,833.00 |
| Sep 30, 2025 | 70,833.00 |
| Jun 30, 2025 | 16,823.00 |
| Jun 30, 2025 | 16,823.00 |
| Mar 31, 2025 | -10,415.00 |
| Mar 31, 2025 | -10,415.00 |
| Dec 31, 2024 | -6,944.00 |
| Dec 31, 2024 | -6,944.00 |
| Sep 30, 2024 | 46,442.00 |
| Sep 30, 2024 | 46,442.00 |
| Jun 30, 2024 | 120,059.00 |
| Jun 30, 2024 | 120,059.00 |
| Mar 31, 2024 | 282,562.00 |
| Mar 31, 2024 | 282,562.00 |
| Dec 31, 2023 | 513,370.00 |
| Dec 31, 2023 | 513,370.00 |